Year |
Citation |
Score |
2024 |
Meqbil YJ, Aguilar J, Blaine AT, Chen L, Cassell RJ, Pradhan AA, van Rijn RM. . The Journal of Pharmacology and Experimental Therapeutics. PMID 38621994 DOI: 10.1124/jpet.123.001735 |
0.772 |
|
2021 |
Meqbil YJ, Su H, Cassell RJ, Mores KL, Gutridge AM, Cummins BR, Chen L, van Rijn RM. Identification of a Novel Delta Opioid Receptor Agonist Chemotype with Potential Negative Allosteric Modulator Capabilities. Molecules (Basel, Switzerland). 26. PMID 34885825 DOI: 10.3390/molecules26237236 |
0.723 |
|
2021 |
Sharma KK, Cassell RJ, Meqbil YJ, Su H, Blaine AT, Cummins BR, Mores KL, Johnson DK, van Rijn RM, Altman RA. Modulating β-arrestin 2 recruitment at the δ- and μ-opioid receptors using peptidomimetic ligands. Rsc Medicinal Chemistry. 12: 1958-1967. PMID 34825191 DOI: 10.1039/d1md00025j |
0.769 |
|
2021 |
Gutridge AM, Chakraborty S, Varga BR, Rhoda ES, French AR, Blaine AT, Royer QH, Cui H, Yuan J, Cassell RJ, Szabó M, Majumdar S, van Rijn RM. Evaluation of Kratom Opioid Derivatives as Potential Treatment Option for Alcohol Use Disorder. Frontiers in Pharmacology. 12: 764885. PMID 34803709 DOI: 10.3389/fphar.2021.764885 |
0.71 |
|
2019 |
Cassell RJ, Sharma KK, Su H, Cummins BR, Cui H, Mores KL, Blaine AT, Altman RA, van Rijn RM. The Meta-Position of Phe in Leu-Enkephalin Regulates Potency, Selectivity, Functional Activity, and Signaling Bias at the Delta and Mu Opioid Receptors. Molecules (Basel, Switzerland). 24. PMID 31842282 DOI: 10.3390/Molecules24244542 |
0.807 |
|
2019 |
Gutridge AM, Robins MT, Cassell RJ, Uprety R, Mores KL, Ko MJ, Pasternak GW, Majumdar S, van Rijn RM. G protein-biased kratom-alkaloids and synthetic carfentanil-amide opioids as potential treatments for alcohol use disorder. British Journal of Pharmacology. PMID 31705528 DOI: 10.1111/Bph.14913 |
0.736 |
|
2019 |
Cai B, Kim D, Akhand S, Sun Y, Cassell R, Alpsoy A, Dykhuizen EC, van Rijn RM, Wendt MK, Krusemark C. Selection of DNA-encoded Libraries to Protein Targets Within and On Living Cells. Journal of the American Chemical Society. PMID 31613623 DOI: 10.1021/Jacs.9B08085 |
0.568 |
|
2019 |
Mores KL, Cummins BR, Cassell RJ, van Rijn RM. A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists. Frontiers in Pharmacology. 10: 407. PMID 31057409 DOI: 10.3389/fphar.2019.00407 |
0.792 |
|
2018 |
Cassell RJ, Mores KL, Zerfas BL, Mahmoud AH, Lill MA, Trader DJ, van Rijn RM. Rubiscolins are naturally occurring G protein-biased delta opioid receptor peptides. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 30591345 DOI: 10.1016/J.Euroneuro.2018.12.013 |
0.772 |
|
2018 |
Mores KL, Cassell RJ, van Rijn RM. Arrestin recruitment and signaling by G protein-coupled receptor heteromers. Neuropharmacology. PMID 30419245 DOI: 10.1016/j.neuropharm.2018.11.010 |
0.672 |
|
Show low-probability matches. |